Equine Health Market Size, Share & COVID-19 Impact Analysis, By Product (Drug Class, {Anti-Infective, Anti-Inflammatory, Parasiticides, and Others}, Vaccines {Inactivated, Live Attenuated, Recombinant, and Others}, and Supplemental Feed Additives), By Disease Type (West Nile Virus, Equine Rabies, Equine Influenza, Equine Herpes Virus, Potomac Horse Fever, Tetanus, and Others), By Distribution Channel (Veterinary Hospitals And Clinics, Retail Pharmacies and Drug Stores, and Others), and Regional Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI101416

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Statistics: Equine Population, By Key Countries, 2022
2. Regulatory Scenario, Equine Health, By Key Countries, 2022
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
4. Technology Advances in Equine Health
5. Impact of Covid-19 on the Market
Global Equine Health Market Analysis, Insights and Forecast, 2019-2030
1. Market Analysis, Insights and Forecast – By Product
  1. Drug Type
    1. Anti-Infectives
    2. Anti-Inflammatory
    3. Parasiticides
    4. Others
  2. Vaccine Type
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Supplemental Feed Additives
2. Market Analysis, Insights and Forecast – By Disease Type
  1. West Nile Virus
  2. Equine Rabies
  3. Equine Influenza
  4. Equine Herpes Virus
  5. Potomac Horse Fever
  6. Tetanus
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals and Clinics
  2. Retail Pharmacies and Drug Stores
  3. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Equine Health Market Analysis, Insights and Forecast, 2019-2030
1. Market Analysis, Insights and Forecast – By Product
  1. Drug Type
    1. Anti-Infectives
    2. Anti-Inflammatory
    3. Parasiticides
    4. Others
  2. Vaccine Type
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Supplemental Feed Additives
2. Market Analysis, Insights and Forecast – By Disease Type
  1. West Nile Virus
  2. Equine Rabies
  3. Equine Influenza
  4. Equine Herpes Virus
  5. Potomac Horse Fever
  6. Tetanus
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals and Clinics
  2. Retail Pharmacies and Drug Stores
  3. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Equine Health Market Analysis, Insights and Forecast, 2019-2030
1. Market Analysis, Insights and Forecast – By Product
  1. Drug Type
    1. Anti-Infectives
    2. Anti-Inflammatory
    3. Parasiticides
    4. Others
  2. Vaccine Type
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Supplemental Feed Additives
2. Market Analysis, Insights and Forecast – By Disease Type
  1. West Nile Virus
  2. Equine Rabies
  3. Equine Influenza
  4. Equine Herpes Virus
  5. Potomac Horse Fever
  6. Tetanus
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals and Clinics
  2. Retail Pharmacies and Drug Stores
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Equine Health Market Analysis, Insights and Forecast, 2019-2030
1. Market Analysis, Insights and Forecast – By Product
  1. Drug Type
    1. Anti-Infectives
    2. Anti-Inflammatory
    3. Parasiticides
    4. Others
  2. Vaccine Type
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Supplemental Feed Additives
2. Market Analysis, Insights and Forecast – By Disease Type
  1. West Nile Virus
  2. Equine Rabies
  3. Equine Influenza
  4. Equine Herpes Virus
  5. Potomac Horse Fever
  6. Tetanus
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals and Clinics
  2. Retail Pharmacies and Drug Stores
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Equine Health Market Analysis, Insights and Forecast, 2019-2030
1. Market Analysis, Insights and Forecast – By Product
  1. Drug Type
    1. Anti-Infectives
    2. Anti-Inflammatory
    3. Parasiticides
    4. Others
  2. Vaccine Type
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Supplemental Feed Additives
2. Market Analysis, Insights and Forecast – By Disease Type
  1. West Nile Virus
  2. Equine Rabies
  3. Equine Influenza
  4. Equine Herpes Virus
  5. Potomac Horse Fever
  6. Tetanus
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals and Clinics
  2. Retail Pharmacies and Drug Stores
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Equine Health Market Analysis, Insights and Forecast, 2019-2030
1. Market Analysis, Insights and Forecast – By Product
  1. Drug Type
    1. Anti-Infectives
    2. Anti-Inflammatory
    3. Parasiticides
    4. Others
  2. Vaccine Type
    1. Inactivated
    2. Live Attenuated
    3. Recombinant
    4. Others
  3. Supplemental Feed Additives
2. Market Analysis, Insights and Forecast – By Disease Type
  1. West Nile Virus
  2. Equine Rabies
  3. Equine Influenza
  4. Equine Herpes Virus
  5. Potomac Horse Fever
  6. Tetanus
  7. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Veterinary Hospitals and Clinics
  2. Retail Pharmacies and Drug Stores
  3. Others
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2022)
2. Company Profiles
  1. Zoetis Services LLC
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  2. Ceva
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  3. Elanco
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  4. Boehringer Ingelheim International GmbH
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  5. Vetoquinol
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  6. Neogen Corporation
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  7. Virbac
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  8. Merck & Co., Inc.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  9. Norbrook
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  10. Purina Animal Nutrition LLC.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  11. Kyoritsuseiyaku Corporation
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  12. Equine Products UK Ltd.
    1. Overview
    2. Product
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)

Read Less

List of Figures

Figure 01: Global Equine Health Market Revenue Breakdown (USD billion, %) by Region, 2022 & 2030

Figure 02: Global Equine Health Market Value Share (%), By Product, 2022 & 2030

Figure 03: Global Equine Health Market Value Share (%), By Disease Type, 2022 & 2030

Figure 04: Global Equine Health Market Value Share (%), By Distribution Channel, 2022 & 2030

Figure 05: Global Equine Health Market Value Share (%), By Region, 2022 & 2030

Figure 06: North America Equine Health Market Value (USD billion), By Product, 2022 & 2030

Figure 07: North America Equine Health Market Value Share (%), By Product, 2022

Figure 08: North America Equine Health Market Value (USD billion), By Disease Type, 2022 & 2030

Figure 09: North America Equine Health Market Value Share (%), By Disease Type, 2022

Figure 10: North America Equine Health Market Value (USD billion), By Distribution Channel, 2022 & 2030

Figure 11: North America Equine Health Market Value Share (%), By Distribution Channel, 2022

Figure 12: North America Equine Health Market Value (USD billion), By Country, 2022 & 2030

Figure 13: North America Equine Health Market Value Share (%), By Country, 2022

Figure 14: Europe Equine Health Market Value (USD billion), By Product, 2022 & 2030

Figure 15: Europe Equine Health Market Value Share (%), By Product, 2022

Figure 16: Europe Equine Health Market Value (USD billion), By Disease Type, 2022 & 2030

Figure 17: Europe Equine Health Market Value Share (%), By Disease Type, 2022

Figure 18: Europe Equine Health Market Value (USD billion), By Distribution Channel, 2022 & 2030

Figure 19: Europe Equine Health Market Value Share (%), By Distribution Channel, 2022

Figure 20: Europe Equine Health Market Value (USD billion), By Country/ Sub-Region, 2022 & 2030

Figure 21: Europe Equine Health Market Value Share (%), By Country/ Sub-Region, 2022

Figure 22: Asia Pacific Equine Health Market Value (USD billion), By Product, 2022 & 2030

Figure 23: Asia Pacific Equine Health Market Value Share (%), By Product, 2022

Figure 24: Asia Pacific Equine Health Market Value (USD billion), By Disease Type, 2022 & 2030

Figure 25: Asia Pacific Equine Health Market Value Share (%), By Disease Type, 2022

Figure 26: Asia Pacific Equine Health Market Value (USD billion), By Distribution Channel, 2022 & 2030

Figure 27: Asia Pacific Equine Health Market Value Share (%), By Distribution Channel, 2022

Figure 28: Asia Pacific Equine Health Market Value (USD billion), By Country/ Sub-Region, 2022 & 2030

Figure 29: Asia Pacific Equine Health Market Value Share (%), By Country/ Sub-Region, 2022

Figure 30: Latin America Equine Health Market Value (USD billion), By Product, 2022 & 2030

Figure 31: Latin America Equine Health Market Value Share (%), By Product, 2022

Figure 32: Latin America Equine Health Market Value (USD billion), By Disease Type, 2022 & 2030

Figure 33: Latin America Equine Health Market Value Share (%), By Disease Type, 2022

Figure 34: Latin America Equine Health Market Value (USD billion), By Distribution Channel, 2022 & 2030

Figure 35: Latin America Equine Health Market Value Share (%), By Distribution Channel, 2022

Figure 36: Latin America Equine Health Market Value (USD billion), By Country/ Sub-Region, 2022 & 2030

Figure 37: Latin America Equine Health Market Value Share (%), By Country/ Sub-Region, 2022

Figure 38: Middle East & Africa Equine Health Market Value (USD billion), By Product, 2022 & 2030

Figure 39: Middle East & Africa Equine Health Market Value Share (%), By Product, 2022

Figure 40: Middle East & Africa Equine Health Market Value (USD billion), By Disease Type, 2022 & 2030

Figure 41: Middle East & Africa Equine Health Market Value Share (%), By Disease Type, 2022

Figure 42: Middle East & Africa Equine Health Market Value (USD billion), By Distribution Channel, 2022 & 2030

Figure 43: Middle East & Africa Equine Health Market Value Share (%), By Distribution Channel, 2022

Figure 44: Middle East & Africa Equine Health Market Value (USD billion), By Country/ Sub-Region, 2022 & 2030

Figure 45: Middle East & Africa Equine Health Market Value Share (%), By Country/ Sub-Region, 2022

Figure 46: The figure besides highlights the market share (%) of companies operating in the global equine health market, 2022.

List of Tables

Table 01: Global Equine Health Market Revenue (USD billion) Forecast, By Product, 2019–2030

Table 02: Global Equine Health Market Revenue (USD billion) Forecast, By Drug Type, 2019–2030

Table 03: Global Equine Health Market Revenue (USD billion) Forecast, By Vaccine Type, 2019–2030

Table 04: Global Equine Health Market Revenue (USD billion) Forecast, By Disease Type, 2019–2030

Table 05: Global Equine Health Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Table 06: Global Equine Health Market Revenue (USD billion) Forecast, By Region, 2019–2030

Table 07: North America Equine Health Market Revenue (USD billion) Forecast, By Product, 2019–2030

Table 08: North America Equine Health Market Revenue (USD billion) Forecast, By Drug Type, 2019–2030

Table 09: North America Equine Health Market Revenue (USD billion) Forecast, By Vaccine Type, 2019–2030

Table 10: North America Equine Health Market Revenue (USD billion) Forecast, By Disease Type, 2019–2030

Table 11: North America Equine Health Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Table 12: North America Equine Health Market Revenue (USD billion) Forecast, By Country, 2019–2030

Table 13: Europe Equine Health Market Revenue (USD billion) Forecast, By Product, 2019–2030

Table 14: Europe Equine Health Market Revenue (USD billion) Forecast, By Drug Type, 2019–2030

Table 15: Europe Equine Health Market Revenue (USD billion) Forecast, By Vaccine Type, 2019–2030

Table 16: Europe Equine Health Market Revenue (USD billion) Forecast, By Disease Type, 2019–2030

Table 17: Europe Equine Health Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Table 18: Europe Equine Health Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019–2030

Table 19: Asia Pacific Equine Health Market Revenue (USD billion) Forecast, By Product, 2019–2030

Table 20: Asia Pacific Equine Health Market Revenue (USD billion) Forecast, By Drug Type, 2019–2030

Table 21: Asia Pacific Equine Health Market Revenue (USD billion) Forecast, By Vaccine Type, 2019–2030

Table 22: Asia Pacific Equine Health Market Revenue (USD billion) Forecast, By Disease Type, 2019–2030

Table 23: Asia Pacific Equine Health Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Table 24: Asia Pacific Equine Health Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019–2030

Table 25: Latin America Equine Health Market Revenue (USD billion) Forecast, By Product, 2019–2030

Table 26: Latin America Equine Health Market Revenue (USD billion) Forecast, By Drug Type, 2019–2030

Table 27: Latin America Equine Health Market Revenue (USD billion) Forecast, By Vaccine Type, 2019–2030

Table 28: Latin America Equine Health Market Revenue (USD billion) Forecast, By Disease Type, 2019–2030

Table 29: Latin America Equine Health Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Table 30: Latin America Equine Health Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019–2030

Table 31: Middle East & Africa Equine Health Market Revenue (USD billion) Forecast, By Product, 2019–2030

Table 32: Middle East & Africa Equine Health Market Revenue (USD billion) Forecast, By Drug Type, 2019–2030

Table 33: Middle East & Africa Equine Health Market Revenue (USD billion) Forecast, By Vaccine Type, 2019–2030

Table 34: Sweden Equine Health Market Revenue (USD billion) Forecast, By Disease Type, 2019–2030

Table 35: Middle East & Africa Equine Health Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Table 36: Middle East & Africa Equine Health Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019–2030

STUDY PERIOD: 2019-2030
BASE YEAR:2022
HISTORICAL DATA: 2019-2021
NO OF PAGES: 164

Consulting Services

Healthcare Clients

Related Reports

Get in Touch with Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
[email protected]